top of page
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Search

When the Lab Gets It Wrong: New York Recalls Cannabis Products Over Testing Issues





By Justice — Elevated Club NYC


New York’s cannabis market just got another reminder that legalization is still a work in progress.


Recently, the New York State Office of Cannabis Management (OCM) announced a precautionary recall of dozens of cannabis product lots after discovering unreliable testing results from a licensed laboratory. The issue centers around a testing facility called Keystone State Testing New York, which regulators say reported inaccurate results on safety screenings.


In total, 55 product lots were recalled, including flower, pre-rolls, edibles, and beverages that had already made their way onto dispensary shelves across the state.


The concern isn’t necessarily that the cannabis itself was confirmed to be unsafe — the problem is that the lab data cannot be trusted.


According to regulators, 54 product lots were incorrectly reported as passing tests for Aspergillus, a potentially harmful mold that can pose risks to consumers with weakened immune systems. Another lot reportedly had incorrect results related to cadmium, a heavy metal that cannabis products are required to screen for.


So the state did what regulators are supposed to do: pause, investigate, and recall the affected batches until their safety can be verified.


For consumers, this might sound alarming. But in reality, recalls like this are part of how regulated markets are supposed to function. Unlike the unregulated market of the past, licensed cannabis in New York must pass strict lab testing before reaching consumers.


Still, this situation highlights a bigger conversation happening across the cannabis industry: lab reliability and oversight.


Testing labs hold enormous influence over the supply chain. They determine potency levels, pesticide compliance, mold safety, and heavy metal thresholds. When lab data is inconsistent or unreliable, it can affect cultivators, processors, retailers, and ultimately the consumer.


For New York’s young cannabis market, moments like this are part of the growing pains of building a regulated system.


Transparency matters. Accountability matters.


And most importantly, consumer trust matters.


At Elevated Club NYC, we believe cannabis consumers deserve clarity about what they’re buying and confidence in the systems meant to protect them. Education is elevation — and staying informed about industry developments is part of being a responsible consumer in this new era of legal cannabis.


The takeaway isn’t panic.


The takeaway is progress.


Because a system that identifies problems and addresses them openly is ultimately a system moving in the right direction.


Stay informed. Stay elevated.lol l

 
 
 

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page